9999999997-12-014602.txt : 20121116 9999999997-12-014602.hdr.sgml : 20121116 20121116144508 ACCESSION NUMBER: 9999999997-12-014602 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20121116 DATE AS OF CHANGE: 20121116 20121116 20121116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 121211347 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T M:"`V,B]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.'094P`C$+`P<#%LP(#`@-C$R(#7!E+T]B:E-T;3X^K(M&TH@ M:9MNL&2A-NL@Y(66:(G!#\%66?KMIY/LQ,L(VUH.^>2[D^]_UH]%0(%)D`FP M&)BP+@$A.7`*,HZ`,V"4";BY(?='\Y`:9;3=/Z0,3U%X'(_)K*Z,C649Q\,V M9K>I#[XO#L[:3>Z,A`GC-RJPT>=[_;&ZJ24W&F?&G$6D5FA=BV(P"F<3NOC M:A2&,8P$E78^:@>G/%J[[$R5>?'R+LM+W<)"_X3'NE35>Y=;J%(3E[$)%U^F MHVE=;.>9RZ>FT6:S)XNZ*57A0D]>DK2*/AE5Y)M)M2LT4)(:77ZU_SGR\V$M M2F[R@ZD;\FTPBAMTJEJ--=?:WU>;>IM7._*45Y.JS4_OL[QIS>U>-2#X11>\ M:+RDSZJK8"PFZ?-W@X*RYED[92=Y]M-;LV]7/*2`%E+OAX8Y(03X&JRXMH:[ MH4G.NR>N*)(0,092QFZ).'%5&$^"P-?9.-;X4V$8N:S_#CWYW@:];65@OT&[ MIX]P&?M)K(_M)!CK56(=*A#G^/JM&$:_8TCEZS#\*X'!%0)C_C8`7\L>IQ?L MNRQ#?O&$LA2-60;O%*E M3549,X2IC,WZLMG\^YZYV$`@41]*%#P>S[E]Y_N.^7"[8O!4#SXE@P])X@.# M9#M@/GCXAY?`BR#V1G3$(=D//'C"_R137\\#`N`D_^#:992%D-S@CMI(?K4+ M-Z#C\?&I2SV/C96Y73P/OI&ORT4R+U6IQOS3NF4?CZ,3]:;&Z(D[9\:D*Z:L3KEWAL67Y0^S7H@(6#<'W$$)M MQQ"*M]V&=!R]JJG#R;,XW3_8_G)N\O8IY]BQSMJW MUJ%OK!9:!N9I7D]A$614>TBHD'P M7HNB\PAD+G,!RY("DLYEWD@]A.G\%_#'7L!,5I2S4Y._KWWT2=0(-QI1T%DF M\B/WO?/2>%<:,YB"X_IQZ"'UNB(5>B-2.6@6D;TS0BB/53L<-X<.DMB47[=K M[$I'04'/:(Y:B) M<*7CWPCSW#]@BQW>``92XE.B]Q')&/VL'8\@&K%1(NVQZ.>42ICUH)PWB7Q* M:^.V$H=*U`B-AACQ9J2&]0LVC4J*G^!C:RSO*P%*3]N7`P7:N#P.A@6^9Y^:QD:%/5KJ_-.-$IYEGF.:ATUP() MF@M-5DQ=N=/9X1LG/F9WP7)3HE:U,FFDPFNLY(Y1"1Q$)OCD2=2(X.OG8J@*@&P/@:-WA2QC'%AOS4(%3E>W3SC[Y+2W: MM'JQ=P$;VA6JFY\-.MX'B=X.$EP/HM_@FM1K-7F1[&8_/HD6]]&NN^;_A^O7 MT/[GP36W/9VBZG539:T4,U0SJY.7E5"GLC&[0F1F-'%-9D.42%6W::'E8G[B M:"^7O3YF2#;(TZ=4O[K:9E=6LGGYV%7T7K7]0K]R\9Q&'3]?%&Q,S29<\`#U MOE<[2OA"[>`/5Y*KA=I)NQT+]F=U\=&X-/?/W?VE:6X>C] M;=8MY$7\WJU-9*J]=VFTZA*2PMS5ZNSX=5(V%QY[Y)PN!JE9,OA7@`$`.LKK MX0T*96YDG)E4WI.5&-Z:V,Y9"(_/@H\>#IX M;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B M92!835`@0V]R92`U+C(M8S`P,2`V,RXQ,SDT,SDL(#(P,3`O,#DO,C&UP.D-R96%T;W)4;V]L/@H@ M("`@("`@("`\>&UP.DUO9&EF>41A=&4^,C`Q,BTQ,2TQ-E0Q-#HT,SHU."TP M-3HP,#PO>&UP.DUO9&EF>41A=&4^"B`@("`@(#PO&UL.FQA;F<] M(G@M9&5F875L="(^36EC&UP34TZ26YS=&%N8V5)1#YU=6ED.C8W,#DS,C`V+3&UP34TZ26YS=&%N8V5)1#X* M("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@)#0IE;F1S=')E86T-96YD;V)J#34@,"!O M8FH-/#PO1&5C;V1E4&%R;7,\/"]#;VQU;6YS(#0O4')E9&EC=&]R(#$R/CXO M1FEL=&5R+T9L871E1&5C;V1E+TE$6SQ"134W0C0T,#$W-D8W.#S@"P&!D8@P?0?2#`R``08`'J:!1L-"F5N9'-T